Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1710115

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1710115

Candida Infection Testing Global Market Report 2025

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Candida infection testing involves diagnostic procedures used to detect the presence of Candida species, which are fungi that can lead to infections in different parts of the body. These tests help identify the type and severity of the Candida infection, allowing for appropriate treatment planning.

The primary types of Candida infection testing are for invasive candidiasis and candidemia. Invasive candidiasis is a serious fungal infection that occurs when Candida yeast enters the bloodstream, spreading to various organs such as the heart, brain, eyes, bones, and other tissues. Testing methods include vaginal pH tests, nucleic acid amplification testing (NAAT), and microbiome tests, applied in settings such as hospitals and laboratories.

The candida infection testing market research report is one of a series of new reports from The Business Research Company that provides candida infection testing market statistics, including candida infection testing industry global market size, regional shares, competitors with a candida infection testing market share, detailed candida infection testing market segments, market trends and opportunities, and any further data you may need to thrive in the candida infection testing industry. This candida infection testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The candida infection testing market size has grown strongly in recent years. It will grow from $15.69 $ billion in 2024 to $16.72 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the rising incidence of candida infections, growing awareness and diagnostics, expansion of healthcare infrastructure, rise in hospital-acquired infections, and increasing funding for research.

The candida infection testing market size is expected to see strong growth in the next few years. It will grow to $21.29 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the emergence of new candida strains, rising awareness of fungal infections, expansion of healthcare access, aging population, rising awareness and preventive healthcare. Major trends in the forecast period include advancements in molecular diagnostics, integration of digital health technologies, integration of AI, integration of machine learning, and personalized medicine.

The growing prevalence of yeast infections is anticipated to drive the expansion of the candida infection testing market. Yeast infections, caused by the overgrowth of the fungus Candida, commonly affect areas such as the mouth, genitals, and skin, leading to symptoms such as itching, redness, and discomfort. Factors such as imbalances in the body's natural bacteria, weakened immune systems, and hormonal changes are key contributors to Candida overgrowth. Candida infection testing plays a crucial role in diagnosing these infections, enabling healthcare providers to confirm the presence of Candida and determine the appropriate treatment. For example, according to GOV.UK in September 2023, the rate of bloodstream infections caused by yeast in England increased to 4.0 per 100,000 population in 2022, reflecting a 4% rise from 2021. This upward trend in yeast infections is expected to fuel growth in the candida infection testing market.

Major players in the candida infection testing market are increasingly focusing on developing advanced technological solutions, such as fully automated PCR rapid tests for detecting Candida. These high-tech diagnostic tools utilize polymerase chain reaction (PCR) technology to provide quick and accurate detection of Candida species in clinical samples. For instance, in May 2024, Bosch Healthcare Solutions GmbH, a medical technology company based in Germany, introduced a PCR test for Candida auris detection on the Vivalytic platform. This test offers fully automated, rapid results within one hour at the point of care, significantly reducing the time required compared to traditional culture methods, which typically take one to three days in centralized laboratories. This innovation is particularly valuable for clinical settings and high-risk patients, enabling timely diagnosis and treatment of serious C. auris infections.

In February 2024, Bruker Corporation, a US-based provider of scientific instruments and analytical solutions, announced the completion of its acquisition of ELITechGroup for approximately €870 million (around $942 million) in cash. This acquisition is a strategic step for Bruker to expand its portfolio in molecular diagnostics and infectious disease testing by incorporating ELITech's innovative technologies and expertise. ELITechGroup, based in France, is a global leader in the in vitro diagnostics (IVD) industry.

Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC

North America was the largest region in the candida infection testing market in 2023. The regions covered in the candida infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the candida infection testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The candida infection testing market includes revenues earned by entities by providing services such as diagnostic testing services, culture testing, consultation services, training and support, and microscopic examination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Candida Infection Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on candida infection testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for candida infection testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The candida infection testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Invasive Candidiasis; Candidemia
  • 2) By Test Type: Vaginal pH Test; Nucleic Acid Amplification Testing (NAAT); Microbiome Test
  • 3) By Application: Hospital; Laboratory
  • Subsegments:
  • 1) By Invasive Candidiasis: Tissue Biopsy Testing; Urine Culture Testing; Blood Culture Testing
  • 2) By Candidemia: Blood Tests; Serological Testing; Molecular Testing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r31694

Table of Contents

1. Executive Summary

2. Candida Infection Testing Market Characteristics

3. Candida Infection Testing Market Trends And Strategies

4. Candida Infection Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Candida Infection Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Candida Infection Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Candida Infection Testing Market Growth Rate Analysis
  • 5.4. Global Candida Infection Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Candida Infection Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Candida Infection Testing Total Addressable Market (TAM)

6. Candida Infection Testing Market Segmentation

  • 6.1. Global Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Candidiasis
  • Candidemia
  • 6.2. Global Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaginal pH Test
  • Nucleic Acid Amplification Testing (NAAT)
  • Microbiome Test
  • 6.3. Global Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Laboratory
  • 6.4. Global Candida Infection Testing Market, Sub-Segmentation Of Invasive Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Biopsy Testing
  • Urine Culture Testing
  • Blood Culture Testing
  • 6.5. Global Candida Infection Testing Market, Sub-Segmentation Of Candidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Serological Testing
  • Molecular Testing

7. Candida Infection Testing Market Regional And Country Analysis

  • 7.1. Global Candida Infection Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Candida Infection Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Candida Infection Testing Market

  • 8.1. Asia-Pacific Candida Infection Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Candida Infection Testing Market

  • 9.1. China Candida Infection Testing Market Overview
  • 9.2. China Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Candida Infection Testing Market

  • 10.1. India Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Candida Infection Testing Market

  • 11.1. Japan Candida Infection Testing Market Overview
  • 11.2. Japan Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Candida Infection Testing Market

  • 12.1. Australia Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Candida Infection Testing Market

  • 13.1. Indonesia Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Candida Infection Testing Market

  • 14.1. South Korea Candida Infection Testing Market Overview
  • 14.2. South Korea Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Candida Infection Testing Market

  • 15.1. Western Europe Candida Infection Testing Market Overview
  • 15.2. Western Europe Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Candida Infection Testing Market

  • 16.1. UK Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Candida Infection Testing Market

  • 17.1. Germany Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Candida Infection Testing Market

  • 18.1. France Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Candida Infection Testing Market

  • 19.1. Italy Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Candida Infection Testing Market

  • 20.1. Spain Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Candida Infection Testing Market

  • 21.1. Eastern Europe Candida Infection Testing Market Overview
  • 21.2. Eastern Europe Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Candida Infection Testing Market

  • 22.1. Russia Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Candida Infection Testing Market

  • 23.1. North America Candida Infection Testing Market Overview
  • 23.2. North America Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Candida Infection Testing Market

  • 24.1. USA Candida Infection Testing Market Overview
  • 24.2. USA Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Candida Infection Testing Market

  • 25.1. Canada Candida Infection Testing Market Overview
  • 25.2. Canada Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Candida Infection Testing Market

  • 26.1. South America Candida Infection Testing Market Overview
  • 26.2. South America Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Candida Infection Testing Market

  • 27.1. Brazil Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Candida Infection Testing Market

  • 28.1. Middle East Candida Infection Testing Market Overview
  • 28.2. Middle East Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Candida Infection Testing Market

  • 29.1. Africa Candida Infection Testing Market Overview
  • 29.2. Africa Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Candida Infection Testing Market Competitive Landscape And Company Profiles

  • 30.1. Candida Infection Testing Market Competitive Landscape
  • 30.2. Candida Infection Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Candida Infection Testing Market Other Major And Innovative Companies

  • 31.1. Hologic Inc.
  • 31.2. bioMerieux SA
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Bruker Corporation
  • 31.5. QIAGEN N.V.
  • 31.6. Cepheid
  • 31.7. Randox Laboratories Ltd.
  • 31.8. Meridian Bioscience Inc.
  • 31.9. DiaSorin S.p.A.
  • 31.10. Sekisui Diagnostics LLC
  • 31.11. Enzo Biochem Inc.
  • 31.12. T2 Biosystems Inc.
  • 31.13. Aidian Oy
  • 31.14. SafeCare LLC
  • 31.15. CHROMagar

32. Global Candida Infection Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Candida Infection Testing Market

34. Recent Developments In The Candida Infection Testing Market

35. Candida Infection Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Candida Infection Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Candida Infection Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Candida Infection Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!